Know What's Happening in HealthTech
Know What's Happening in HealthTech
Kontakt.io announced a suite of AI‑driven agents at ViVE 2026, combining real‑time location services (RTLS) with electronic health record data to create a digital twin of hospital operations. The portfolio—Patient Journey Analytics, Access Agent, Patient Flow Agent, and Supply Chain Agent—promises to boost exam‑room utilization, cut equipment search time, and improve bed turnover without new infrastructure. Early data suggest up to 20% higher room usage, $34,000 more revenue per exam room, and $4 million annual savings for a 200‑bed hospital. The solution builds on Kontakt.io’s existing deployment of over four million IoT devices.
Pontiro, a health‑tech firm that streamlines medical‑image data for AI, secured £357,500 in a round led by SFC Capital with participation from Plug and Play Ventures and the British Business Bank. The company’s platform has already processed more than two...
Johnson & Johnson announced a $1 billion investment to build a next‑generation cell‑therapy manufacturing facility in Montgomery County, Pennsylvania, slated to support 500 skilled jobs. The hub is a key element of J&J’s $55 billion U.S. manufacturing, R&D, and technology strategy. Meanwhile,...
En Carta Diagnostics announced that its EC Pocket Lyme test has received FDA Breakthrough Device Designation, accelerating its path to U.S. market entry. The point‑of‑need molecular assay detects Borrelia DNA directly from skin interstitial fluid using a microneedle sampler, delivering...
AngioDynamics announced that its NanoKnife system now holds European CE‑mark indications for soft‑tissue ablation of liver, kidney, prostate and pancreas tumours, including intermediate‑risk prostate cancer. The device uses irreversible electroporation (IRE), a non‑thermal technology that destroys cancer cells while sparing...
A £4.2 million Northern Ophthalmic Research and Innovation Institute (NORI) is being established in North East England to turn routine eye scans into early‑warning tools for serious illnesses. The hub, hosted by the University of Sunderland, will link eye images with...
Leica Biosystems, a Danaher subsidiary, unveiled the Leica CM1950 cryostat equipped with DualEcoTec cooling. The device cools specimens up to three times faster and chambers up to twice as fast, slashing setup and case times. It employs a near‑zero global...
The NHS is rapidly adopting AI and patient‑facing tools, yet back‑office staff such as roster managers remain stuck with outdated systems. This digital divide fuels stress, mismatched rotas, and higher temporary‑staff costs, contributing to the wider retention crisis. Trusts that...
University of Bristol engineer Dr. Jiayang Li has created a smart shoe insole equipped with 253 micro‑sensors that map pressure and gait in real time. The device consumes only 100 microwatts, enabling up to three months of operation on a...
Grail announced that its Galleri multi‑cancer blood test failed to achieve the primary endpoint in a large United Kingdom clinical trial. The study, which evaluated the test’s ability to detect early‑stage cancers across dozens of tumor types, showed promising signals...
Pison Perform is a wrist‑worn wearable that uses medical‑grade electroneurography (ENG) to capture brain‑derived signals and deliver daily scores on reaction time, inhibition control, and sustained focus. After six months of testing, the reviewer recorded a 41.5 ms readiness gain and...
Researchers at the University of Pennsylvania and Harvard have created an ultrathin, flexible electronic mesh that can be implanted into developing pancreatic tissue. The mesh delivers a 24‑hour rhythmic electrical pulse, coaxing stem‑cell‑derived islet cells toward functional maturity and synchronized...
Researchers have demonstrated that combining 18F‑FDG PET with high‑resolution MRI can reliably separate limbic‑predominant age‑related TDP‑43 encephalopathy (LATE) from Alzheimer’s disease in living patients. By creating stereotactic surface projection PET templates from autopsy‑confirmed cases and integrating MRI volumetry, the team...
Utah’s Department of Health has green‑lit a 12‑month pilot that lets an approved artificial‑intelligence system automatically process prescription refills for chronic medications. The AI checks dosage, patient history, and insurance eligibility before sending the order to participating pharmacies, aiming to...
ViVE 2025 convened leading health‑tech innovators to examine how security, artificial intelligence and other emerging technologies are reshaping digital health. Speakers highlighted AI‑driven diagnostics, robust cybersecurity frameworks, and interoperable platforms as essential for scaling patient‑centric care. The event also showcased...
A collaborative team led by UNSW and Nutromics has demonstrated a wearable patch that continuously measures vancomycin levels using DNA‑based aptamer sensors. Published in Nature Biotechnology, the pilot trial showed the patch can track drug concentration in interstitial fluid, offering...
Grail’s multi‑cancer blood test Galleri failed to meet its primary endpoint in a large NHS‑partnered study, casting doubt on its early‑detection claims. The test, priced at $1,000, generated $136.8 million from 185,000 units sold in 2025 but remains unapproved by the...
Chronilogix announced an integration that embeds its AI‑powered coaching technology into the Balance for Life wellness app. The combined solution delivers on‑demand behavioral health support for depression, anxiety and stress, while also addressing chronic condition management. By offering 24/7 personalized...
Dock Health announced that its productivity platform is now deployed at Mayo Clinic to automate referral and specialty workflows across cardiovascular, e‑consult and contract programs. The solution creates structured, real‑time workflows that trigger when orders enter the EHR, automatically assigning...
BioVentrix, a Massachusetts medtech firm developing the Revivent heart‑failure system, filed an IPO prospectus on Feb. 12, targeting a Nasdaq listing under BVXX. The company estimates a $10 billion valuation in the U.S. and $16 billion globally. Revivent, a minimally invasive LV reconstruction...
Meta is set to revive its smartwatch project with a 2026 launch under the codename “Malibu 2.” The new device will prioritize health tracking and deep integration with Meta’s AI services, diverging from earlier Android‑based concepts. In parallel, Meta plans to...
GE HealthCare announced FDA clearance for three next‑generation MRI products: the 1.5‑T Signa Sprint with Freelium, the 3‑T Signa Bolt, and the AI‑driven workflow platform Signa One. The Sprint uses a helium‑free magnet that consumes less than 1 % of traditional coolant, while the...
MIT researchers have created a miniature ultrasound system roughly the size of a smartphone and costing about $300, capable of capturing real‑time three‑dimensional breast images. The device uses a square‑array probe with CODA geometry, reducing transducer elements from 1,024 to...
Amazfit, Zepp Health’s flagship wearable brand, launched the T‑Rex Ultra 2, a rugged GPS smartwatch aimed at extreme‑environment users. The device combines comprehensive biotracking—heart rate, SpO₂, sleep, breathing, and stress metrics—with 30‑day battery life, 100‑metre water resistance, and a Low Temperature...
Health systems are turning to cloud‑based generative AI to slash documentation overload. City of Hope deployed HopeLLM, an agentic large‑language‑model platform that creates concise medical‑history summaries in minutes, freeing clinicians from nightly “pajama time.” Providence built Provaria on Azure, using...
Hims & Hers Health announced a definitive agreement to acquire Australian digital‑health firm Eucalyptus for up to $1.15 billion, with $240 million paid in cash and the balance structured as deferred and earn‑out payments. Eucalyptus, founded in 2019, serves more than 775,000...
CareYaya, a student‑matching platform, connects college students with seniors and disabled adults to provide non‑medical in‑home assistance. By paying students directly at about $20 an hour, the service reduces care costs roughly 50 % compared with traditional agencies. The app’s algorithm...
MedStar Health is scaling its Signature concierge primary‑care program by partnering with Withings Health Solutions to supply patients with cellular blood‑pressure cuffs and scales. The collaboration leverages MedStar’s existing telehealth and remote‑patient‑monitoring infrastructure to collect real‑world physiologic data outside the...
Altera Digital Health announced the appointment of Sean Sykes as Executive Vice President for its Ventus portfolio, which delivers integrated revenue cycle and administrative solutions. Sykes brings more than 20 years of experience building high‑performing sales and customer‑success teams in...
Triplemoon announced that Dr. Caroline Carney, CEO of Magellan Health and dual board‑certified psychiatrist‑internist, has joined its Board of Directors. The appointment coincides with a $3.5 million seed round led by Activate Venture Partners and LiveOak Ventures aimed at scaling its...
Medtronic’s Symplicity Spyral renal denervation system has secured reimbursement approval from Japan’s Ministry of Health, Labour and Welfare, expanding coverage for resistant hypertension. The therapy, which uses radio‑frequency energy to ablate renal nerves via a single catheter, was previously approved...
San Juan Regional Medical Center in Farmington, New Mexico, has rolled out Wellsheet’s AI documentation platform across its entire enterprise. The solution, already active in more than 100 U.S. hospitals, promises physicians 90‑120 minutes of daily documentation savings and a...
The FDA issued an early alert after linking Trividia Health’s True Metrix glucometers to 114 injuries and one death. The alert cites an E‑5 error code that appears when blood glucose exceeds 600 mg/dL or when a test‑strip fault occurs, potentially...
SMART Health IT team submitted formal comments on HTI-5. Feel free to read and borrow language. Briefly: Deregulation should not mean losing sight of whether interoperability is actually working. (HTI-5 risks eliminating the instrumentation ASTP/ONC needs to steer a successful...
A study of 93 adults in remission from major depressive disorder used research‑grade wrist actigraphy to monitor sleep and activity for up to two years. The analysis of nearly 32,000 days of data showed that increasingly irregular sleep patterns and...
Health systems are accelerating digital transformation post‑COVID, with HIMSS research showing that hospitals possessing advanced digital maturity are 3.25 times more likely to earn higher safety grades and experience lower infection and adverse event rates. The pandemic also shifted patients from...
Healthcare’s imaging assets—radiology and digital pathology—are evolving from isolated diagnostic tools into a strategic, enterprise‑wide intelligence layer. Current PACS and VNA infrastructures were built for episodic access, limiting data recombination, longitudinal analysis, and outcome linkage. The article argues that achieving...
Should residents and med students get access to AI scribes? Or does it risk critically de-skilling them? My 7 thoughts: 1/ Students are increasingly using scribes in all aspects of their life. I’m not in school anymore but I suspect many...
A key study of $GRAL's Galleri test in the UK failed to reach its primary endpoint, but showed benefits on a secondary endpoint. Tell me what you all think. https://t.co/CDrvokqPop
Medplum, an open‑source headless EHR serving over 20 million patients, migrated its production containers to Docker Hardened Images (DHI) with just 54 lines of code changes across five files. The switch replaced custom hardening scripts with Docker’s secure‑by‑default base images, eliminating...
The most used multicancer early detection (MCED) blood test (liquid biopsy) uses methylation (GRAIL). But combining that with DNA fragmentomics, as reported today @NatureCancer, improves early detection https://t.co/VkNDR4XuW3
What happens when you drop great tech into a fee-for-service system? Farzad Mostashari has a blunt answer—and it’s worth hearing. See what Aledade is doing to make the math work for value-based care: https://t.co/iMKzsdQSrl @AledadeACO #ValueBasedCare #HITsm https://t.co/lL49Ha2UHC
Obesity affects over 42% of U.S. adults, prompting a surge in weight‑loss solutions. Technology‑enabled medical centers combine clinical expertise with digital tools to deliver data‑driven, personalized programs. By continuously monitoring biomarkers, body composition and activity, they adapt nutrition and exercise...
Predicting when symptoms of Alzheimer's disease will occur with elevated p-tau217 blood test and a person's age, even 20+ years in advance @NatureMedicine https://t.co/EYaGglBh1H
👍Profusa is my pick for 2026. Fascinating technology to measure real time tissue biochemistry. This is a fundamental shift from blood to tissue to shine a new light on cellular status and metabolism. https://t.co/gfduGvgJTX @ProfusaInc #medicine $PFSA #diabetes
The FNIH Biomarkers Consortium unveiled a “clock model” that uses a single blood test to forecast Alzheimer’s disease symptom onset 3‑4 years before clinical presentation. The model aggregates plasma biomarkers into a temporal trajectory, and a new web‑based visualization tool...
SEQSTER PDM, Inc. unveiled its 1-Click Data Refinery™ – an enterprise‑grade engine that converts raw, patient‑consented EHR data into clean, structured, AI‑ready records. The platform normalizes, deduplicates and harmonizes data across health systems, delivering longitudinal patient views suitable for rapid...
GekkoVet and Royal Canin have launched their AI‑driven veterinary decision‑support platform in Mexico, marking the first rollout of the partnership in Latin America after a successful Asian pilot. The integration equips clinics with real‑time diagnostics, treatment recommendations, and drug information within...
Australian telehealth startup Eucalyptus is being acquired by NYSE‑listed Hims & Hers for $1.15 bn, valuing the company at A$1.6 bn. The deal includes an upfront $240 m payment and deferred cash or stock plus earn‑out provisions through 2029. Eucalyptus reports an ARR north...
Radiopharmaceutical therapy (RPT) utilization among Medicare beneficiaries surged 2,000% between 2013 and 2023, climbing from 529 to 12,395 IV administrations. The study identified a 37% compound annual growth rate, with diagnostic and interventional radiology delivering 45.2% of services and nuclear...
